Marc Sedam, Vice Provost for Innovation and New Ventures and Managing Director of UNHInnovation. Joining the Universityof New Hampshire in 2010, Sedam has an extensive background in intellectual asset management, licensing, and start‐upformation.
In addition to his position with UNH, Sedam serves as the Executive Director of the New Hampshire Innovation ResearchCenter, New Hampshire’s only translational research funding program; is the current Chair of AUTM, a global nonprofit leader in efforts to educate, promote and inspire professionals to support the development of academic research; was the founding director of the Peter T. Paul Entrepreneurship Center; and is the Principal Investigator of UNH’s National Science Foundation I‐Corps Site. Sedam recently led the charge in launching a CLIA Certified COVID Testing Lab at UNH, which is critical to continuing in‐person education and on‐campus operations for the university during the pandemic.
Sedam is very active in building New Hampshire’s innovation ecosystem. UNH has been the largest financial supporter of the NH startup community, and since 2010 has invested over $1.5MM. In 2017, UNH was awarded the “Campus Culture and PolicyAward” from VentureWell, a leader in funding, training, coaching and early investment that brings student innovations to the world, for its rapidly scaled efforts to maximize student engagement and forge connections across campus silos.
Since its inception in 2014, Sedam has been a member of NH’s “Live Free and Start” advisory council, an initiative designed to help the state’s high‐tech companies succeed. Sedam has served on the Board of Directors of NHICC/AlphaLoft from 2011‐2016 and as Vice‐Chair of the Board of Alpha Loft between 2014‐ 2015. He also serves as an advisor on the boards of two non‐profits founded at UNH as well as served on the AUTM Board of Directors, and as the AUTM Vice President for Professional Development, a role responsible for the education and training activities for AUTM members. Sedam has recently been asked to serve as advisor to a venture capital firm on their life sciences portfolio and engagement within the university technology transfer community.
Prior to UNH, Sedam was the Chief Operating Officer of Qualyst, Inc., the global leader in the study of pharmaceutically relevant drug transport interactions (acquired in 2017 by BioreclamationIVT). Sedam also served as the Associate Director for Life Sciences of the Technology Transfer Office at the University of North Carolina at Chapel Hill, helping make UNC one of thetop US universities in start‐up formation in 2001. He worked at National Starch and Chemical Company as a food enzymologist and was an inventor on a patented product with peak sales exceeding $50MM/year. In 2003, the product won “Product of the Year” from the Institute for Food Technology.
Sedam has a B.S. in biochemistry from the University of New Hampshire and an MBA from the University of North Carolina atChapel Hill’s Kenan‐Flagler Business School with a focus on entrepreneurship and new ventures. Additionally, Sedam is internationally recognized as an expert in the fields of innovation commercialization, early stage startup support, regional ecosystem development, technology transfer, and innovation policy.